Last reviewed · How we verify
Ascorbic Acid 500 MG
Ascorbic Acid 500 MG, marketed by Ain Shams University, is a well-established vitamin C supplement with a key composition patent expiring in 2028. The drug's primary strength lies in its broad availability and recognized health benefits, positioning it as a staple in the dietary supplement market. The primary risk is the potential increase in competition post-patent expiry, which could erode market share and revenue.
At a glance
| Generic name | Ascorbic Acid 500 MG |
|---|---|
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of L-arginine and Liposomial Vitamin C on Severe Copd Patients Undergoing Pulmonary Rehabilitation. (NA)
- Renoprotective Role of Vitamin C and Coenzyme Q10 in Nephrotoxicity (PHASE2, PHASE3)
- Vitamin C With Steroids for Gastrointestinal GVHD (EARLY_PHASE1)
- The Effect of Nutritional Supplementation on Actinic Purpura: A Pilot Study (NA)
- Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) (PHASE2)
- Oral Vitamin C Administration on Erythropoietin Dosing Requirement in End-Stage Renal Disease Patients on Regular Hemodialysis (NA)
- Effects of Dietary Nitrate and Vitamin C Co-supplementation on Blood Pressure and Endothelial Function in Overweight Individuals (NA)
- PEG-Asc Vs. SPMC for Bowel Preparation in Capsule-based Procedures (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ascorbic Acid 500 MG CI brief — competitive landscape report
- Ascorbic Acid 500 MG updates RSS · CI watch RSS
- Ain Shams University portfolio CI